Join the 200th Anniversary Celebration

Original Article

Cumulative Effects of High Cholesterol Levels, High Blood Pressure, and Cigarette Smoking on Carotid Stenosis

Peter W.F. Wilson, M.D., Jeffrey M. Hoeg, M.D., Ralph B. D'Agostino, Ph.D., Halit Silbershatz, Ph.D., Albert M. Belanger, M.A., Harold Poehlmann, M.S., Daniel O'Leary, M.D., and Philip A. Wolf, M.D.

N Engl J Med 1997; 337:516-522August 21, 1997

Abstract

Background

Single measurements of cardiovascular risk factors may not accurately reflect a person's past exposure to those risk factors. We therefore studied the long-term associations of cardiovascular risk factors such as high serum cholesterol levels, high blood pressure, and cigarette smoking with the prevalence of carotid stenosis.

Methods

We studied cross-sectional and longitudinal information from a sample of 429 men and 661 women in the Framingham Heart Study who underwent B-mode ultrasound measurements of the carotid artery. Their mean age was 75 years, and each had attended most of the biennial clinic examinations over the 34 years before the carotid ultrasound study. We used time-integrated measurements to assess the associations between various cardiovascular risk factors and the degree of carotid stenosis.

Results

Moderate carotid stenosis (>25 percent) was present in 189 men and 226 women. We assessed the odds ratios for this degree of stenosis as compared with minimal stenosis (<25 percent) according to increases in risk factors. In the men, the odds ratio for moderate carotid stenosis associated with an increase of 20 mm Hg in systolic blood pressure was 2.11 (95 percent confidence interval, 1.51 to 2.97). The odds ratio for an increase of 10 mg per deciliter (0.26 mmol per liter) in the cholesterol level was 1.10 (95 percent confidence interval, 1.03 to 1.16), and for an increase of five pack-years of smoking it was 1.08 (95 percent confidence interval, 1.03 to 1.13). The results were similar in the women. Time-integrated measurements of diastolic blood pressure showed significant associations with carotid stenosis in men and insignificant associations in women.

Conclusions

Over the long term, high systolic blood pressure, high cholesterol levels, and smoking were associated with an increased risk of carotid stenosis in this elderly population.

Media in This Article

Figure 2Mean Diastolic Blood Pressure in Men and Women at 17 Biennial Examinations, According to the Severity of Carotid Stenosis as Determined by B-Mode Ultrasonography at the 20th Biennial Examination (1988).
Figure 1Mean Systolic Blood Pressure in Men and Women at 17 Biennial Examinations, According to the Severity of Carotid Stenosis as Determined by B-Mode Ultrasonography at the 20th Biennial Examination (1988).
Article

The effect of risk factors such as high levels of serum cholesterol and high-density lipoprotein (HDL) cholesterol, high blood pressure, and cigarette smoking on the incidence of coronary disease in middle-aged people has been well described.1-3 Less certain, however, is the role of these risk factors in older people and the degree to which they are associated with vascular abnormalities detected by noninvasive techniques.4-6 Cross-sectional studies of these traditional risk factors, accompanied by assessments of carotid stenosis by ultrasound techniques, are beginning to delineate the effect of these biochemical, biologic, and behavioral factors on the atherosclerotic process.

Interest in screening carotid arteries has increased as studies have demonstrated that carotid endarterectomy can prevent stroke in symptomatic persons with more than 70 percent stenosis7,8 and in asymptomatic persons with at least 60 percent stenosis.9 Data from most cross-sectional studies have shown that clinical factors measured at the time of noninvasive testing, such as blood pressure, total cholesterol, HDL cholesterol, and smoking, are not highly associated with stenosis,10,11 although reports based on data from middle-aged adults suggest that abnormal levels of traditional risk factors are associated with greater thickness of the intima of the carotid artery.5,12-16 Authors have noted that the measurement of a risk factor at a single point in time may not accurately reflect a person's past exposure to that factor. This may be particularly important for older people, among whom weight loss, declining health, and a decline in some risk factors are prevalent.17,18

Since total cholesterol levels typically peak in middle age and decline in the elderly, single evaluations of risk factors may underestimate associations with clinical or subclinical vascular disease in older people.17 With these issues in mind, we undertook the present study, in which we compared current measurements, using summary time-integrated estimates of risk factors, with the degree of carotid stenosis as determined by B-mode ultrasonography.

Methods

Subjects and Measurement of Risk Factors

Subjects considered for this investigation were surviving members of the original cohort of the Framingham Heart Study who participated in examination 20 (1988–1989) and had carotid ultrasound examinations performed. During the clinic visit, a history was obtained and a physical examination was performed. Persons who reported having smoked cigarettes during the previous year were classified as smokers and were asked a follow-up question about the number of cigarettes they smoked per day on a regular basis. Blood pressure was measured after subjects had been seated for at least five minutes. Two blood-pressure measurements were taken, and the average values were used in the analyses. Blood was drawn from nonfasting subjects, and cholesterol and HDL cholesterol were measured by enzymatic assays.19

Over the course of the previous 34 years (biennial examinations 3 through 19), the cholesterol levels of the study participants were measured at 11 examinations. Nonenzymatic laboratory methods were used until examination 20.20 The third biennial examination was used as the base line for this study because of previously reported regression to the mean in risk-factor measurements, which was particularly evident for blood pressure shortly after the study's inception.21 Of the subjects whose cholesterol was measured and whose carotid arteries were evaluated at examination 20 (1189 subjects), only those who had attended six or more of the examinations at which cholesterol was measured were considered for this study (1090 subjects). Nonfasting cholesterol levels were determined at all but the 11th examination,20 HDL cholesterol was measured at the 11th and 15th examinations, and blood pressure and the number of cigarettes smoked daily were recorded at all examinations. Each subject's exposure to each of these factors before the carotid evaluation was determined on the basis of the mean levels for that subject over the course of the study; antecedent averages for blood pressure, smoking, and total cholesterol were calculated from examinations 3 to 19, and averages for HDL cholesterol and the ratio of total to HDL cholesterol from examinations 11 and 15. The summary variable for smoking was determined by calculating the number of pack-years each subject smoked during the observation period.

Ultrasonography

A total of 1090 subjects underwent ultrasonography with an Ultrasonix high-resolution, real-time scanner with a 7.5-MHz imaging transducer, a 4-MHz pulse-wave Doppler transducer, and a 4-MHz continuous-wave transducer.4 Projections of the carotid bifurcation were obtained on each side at three locations: the distal 1 cm of the common carotid artery, the carotid bulb, and the proximal 1 cm of the internal carotid artery. Frozen images, captured on a Mitsubishi page printer, and short segments of real-time scanning to demonstrate motion were recorded on videotape for later interpretation. Continuous-wave Doppler recording of the external carotid artery and both pulse-wave and continuous-wave recording of the carotid bifurcation exclusive of the external carotid artery were obtained at the site of maximal disturbance of flow.

Plaque thickness was measured with hand-held calipers in the near and far walls, exclusive of the external carotid artery, at the site of maximal disease in each view. The total plaque thickness was calculated by combining the measurements for the near and far walls. The residual lumen was measured at the site of maximal luminal narrowing, and the unobstructed lumen was measured just distal to the site of any wall abnormality. Peak systolic velocities and frequencies were recorded at the sites of maximal flow disturbance. The degree of vascular stenosis was estimated by a composite of both Doppler spectral criteria and assessment of gray-scale images. The maximal percent stenosis of the two arteries was used for this report.4

Quality control for the carotid measurements included second examinations and readings for 25 subjects within three months of their original evaluations. After estimation of the degree of maximal carotid stenosis in increments of 5 percent, the Pearson correlation coefficient for the method was 0.89. When the maximal carotid stenosis was categorized according to percentage (0, 1 to 24, 25 to 49, and >50 percent), the intraclass correlation coefficient was 0.86 (95 percent confidence interval, 0.72 to 0.93).

Statistical Analysis

Statistical methods included a general linear regression model, with adjustment for age, to compare mean levels of the risk factors22 and age-adjusted logistic regression to test for associations between moderate (>25 percent) and minimal (<25 percent) carotid stenosis.23 Similar age-adjusted logistic-regression analyses were also undertaken to compare severe (>50 percent) with less severe (<50 percent) carotid stenosis. The adult average levels of cholesterol, HDL cholesterol, blood pressure, and smoking at earlier examinations were calculated for each subject within each carotid-stenosis category, and separate analyses were performed for men and women.

Results

Mean (±SE) risk-factor levels are shown in Table 1Table 1Age-Adjusted Mean Levels of Risk Factors According to the Degree of Carotid Stenosis, 1987 to 1989. according to the degree of stenosis. The relative frequency of specific current risk-factor levels is shown in Table 2Table 2Distribution of Current Risk-Factor Categories According to the Degree of Carotid Stenosis, 1987 to 1989.. For instance, there were 90 men with 0 percent stenosis, of whom 54 percent had systolic pressures of 140 mm Hg or higher and 23 percent had diastolic pressures of 90 mm Hg or higher.

The associations of risk factors with the presence of at least 25 percent carotid stenosis as compared with less than 25 percent stenosis are shown in Table 3Table 3Age-Adjusted Odds Ratios for >25 Percent versus ,25 Percent Carotid Stenosis, According to Current and Time-Integrated Risk-Factor Levels.. The values in the tables represent the estimated age-adjusted effects of specified differences in given variables. For instance, among women the estimated odds ratio for at least 25 percent carotid stenosis associated with an increase of 20 mm Hg in systolic blood pressure was 1.16 (95 percent confidence interval, 1.02 to 1.35); for an increase of 20 mm Hg in diastolic pressure it was 0.60 (95 percent confidence interval, 0.44 to 0.82), and for current smoking it was 2.60 (95 percent confidence interval, 1.57 to 4.30). A positive association with systolic pressure and an inverse association with diastolic pressure were evident in women when current blood-pressure levels were used in the analysis. None of the current risk-factor levels were associated with carotid stenosis of at least 25 percent in men.

Associations between the time-integrated risk-factor levels and moderate carotid stenosis appear in Table 3. There were significant associations among men and women for systolic pressure and total cholesterol. For instance, among men the odds ratio for at least 25 percent carotid stenosis that was associated with an increase of 20 mm Hg in systolic blood pressure was 2.11 (95 percent confidence interval, 1.51 to 2.97), and for an increase of 10 mg per deciliter in cholesterol it was 1.10 (95 percent confidence interval, 1.03 to 1.16). The time-integrated measurements of systolic pressure and cholesterol generally showed higher degrees of association with carotid stenosis than were evident for the levels that had been measured at the time of the carotid evaluations. The degree of association between the time-integrated measurement of cigarette smoking and moderate carotid stenosis was generally similar to the result obtained with the measurement of current smoking. The associations between moderate carotid stenosis and time-integrated measurements of diastolic pressure were generally positive, in contrast to what was observed for current levels of diastolic pressure. Time-integrated measurements of the ratio of total cholesterol to HDL cholesterol were associated with moderate carotid stenosis in women, for whom the odds ratio associated with a one-unit increase was 1.19 (95 percent confidence interval, 1.05 to 1.34), but the result was not significant in men, for whom the corresponding odds ratio was 1.07 (95 percent confidence interval, 0.95 to 1.21).

In an analysis restricted to subjects who had not smoked during the 10 years before the ultrasound evaluation, a history of smoking 10 or more years before the evaluation was associated with at least 25 percent carotid stenosis as compared with less than 25 percent stenosis in men (P = 0.038 for smoking 10 years earlier and P = 0.042 for smoking more than 10 years earlier) and women (P<0.001 and P = 0.065, respectively) (data not shown).

Additional age-adjusted logistic-regression analyses were undertaken to test for factors associated with carotid stenosis of >50 percent as compared with <50 percent. The results for >50 percent and >25 percent stenosis tended to be similar in men. On the other hand, the odds ratios in the current and time-integrated analyses for >50 percent carotid stenosis were generally stronger for lipid factors in women. For instance, the odds ratio associated with an increase of 10 mg per deciliter in cholesterol for women was 1.12 (95 percent confidence interval, 1.04 to 1.21) for current levels and 1.22 (95 percent confidence interval, 1.13 to 1.32) for time-integrated levels. Similarly, the odds ratio associated with a one-unit increase in the ratio of total cholesterol to HDL cholesterol for women was 1.34 (95 percent confidence interval, 1.13 to 1.59) for current levels and 1.50 (95 percent confidence interval, 1.25 to 1.80) for time-integrated levels.

Mean levels of systolic blood pressure in men and women who had carotid evaluations at examination 20 are shown in Figure 1Figure 1Mean Systolic Blood Pressure in Men and Women at 17 Biennial Examinations, According to the Severity of Carotid Stenosis as Determined by B-Mode Ultrasonography at the 20th Biennial Examination (1988).. Men and women with greater degrees of stenosis tended to have higher systolic blood pressures throughout the 34 years of observation. Analogous figures for mean diastolic blood pressure are shown in Figure 2Figure 2Mean Diastolic Blood Pressure in Men and Women at 17 Biennial Examinations, According to the Severity of Carotid Stenosis as Determined by B-Mode Ultrasonography at the 20th Biennial Examination (1988)., and the corresponding data for mean cholesterol levels are shown in Figure 3Figure 3Mean Cholesterol Levels in Men and Women at 12 Biennial Examinations Spanning 34 Years, According to the Severity of Carotid Stenosis as Determined by B-Mode Ultrasonography at the 20th Biennial Examination (1988).. As with systolic blood pressure, higher mean cholesterol levels were associated with greater degrees of carotid stenosis. At biennial examination 20, however, these distributions were attenuated dramatically.

Discussion

Several investigators have reported that the association between risk factors and clinical coronary heart disease grows weaker in the elderly.17,18,24-26 For instance, young adults and middle-aged people with vascular disease commonly have higher total cholesterol levels, but the apparent effect of cholesterol on vascular disease wanes after the age of 50 years and almost disappears after 65.27 On the other hand, associations between HDL cholesterol and coronary heart disease tend to persist.26,28

Reports have also focused on associations between risk factors and carotid abnormalities detected by ultrasonography.13-15,29-31 Results often differ, and it is important to know the population being studied, the age group, and the carotid abnormality described. For instance, among Finns 42 to 60 years of age, there were strong associations between carotid stenosis and lipids (low-density lipoprotein and HDL cholesterol) but no significant association with blood pressure.29 On the other hand, the Atherosclerosis Risk in Communities investigators, studying more than 7000 American men and women 45 to 64 years of age, found relatively little stenosis in their population sample. Those researchers focused on significant correlations between preclinical disease, the intimal medial thickness of the carotid artery — a diagnostic measure not available in the current study — and a large variety of risk factors, such as high lipoprotein levels, smoking, high blood pressure, high glucose levels, hematologic measures, and genetic markers.12-14 It is now accepted that the intimal medial thickness of the distal common carotid artery is an indicator of early atherosclerotic disease,32 although the zone of thickening is distinct from the plaques that form in the proximal internal carotid artery.33 The findings for moderate carotid stenosis were emphasized in this report, although comparable findings were available on the smaller number of people with severe stenosis.

This study emphasizes that contemporaneous measurements of systolic pressure, diastolic pressure, and smoking appear to be associated with moderate carotid stenosis in women but not in men. Associations between risk factors and carotid stenosis were more consistent for both sexes when time-integrated measurements of exposure over a period of 34 years were used. Similar dose–duration concepts have been used to study familial hypercholesterolemia and vascular disease in young adults. A person's lifetime cholesterol level has been highly associated with the width of his or her Achilles' tendon as determined by computed tomography and with calcified stenoses of coronary-vessel ostia as seen on ultrafast computed tomography.34-36 Recent reports have also demonstrated that intimal medial thickening of the carotid bulb was present in approximately 75 percent of middle-aged men and women with familial hypercholesterolemia.37

Carotid stenosis appears to be positively associated with current systolic pressure and inversely associated with current diastolic pressure in women (Table 3). Similar trends, though not statistically significant, were observed in men. Such findings must be interpreted with caution, because the time-integrated analyses of diastolic pressure tended to be positively associated with moderate carotid stenosis, although the results did not reach statistical significance. It is probable that elderly persons with known vascular disease are more likely to be receiving therapy for hypertension, and the inverse effect of diastolic blood pressure may simply reflect intervention.

The strongly positive association between the time-integrated measurement of systolic pressure and carotid stenosis is a reminder of the importance of systolic pressure in determining the risk of vascular disease. For instance, the systolic pressure was more highly associated with coronary heart disease and stroke than the diastolic pressure in the Framingham Heart Study.38,39 Although clinical practice typically emphasizes the role of diastolic pressure, this finding underscores the importance of systolic pressure and its role in increasing the risk of clinical and subclinical sequelae of vascular disease.

The relation between vascular disease and the time-integrated measurement of a risk factor can be expected to be stronger than the association with a single measurement for a variety of reasons. Multiple measurements of the same variable may classify persons more accurately, because there may be significant laboratory or biologic variation in the factor under consideration and risk-factor levels may change unpredictably among older persons.40-42 Laboratory methods were relatively uniform over the course of the study. Cholesterol and HDL cholesterol were generally measured in the nonfasting state, and the reported difference between measurements of these analytes in the fasting and nonfasting states is minimal.41,43 Laboratory methods also evolved over time, but quality control of the enzymatic measurements of lipoprotein cholesterol was linked to the Abell–Kendall methods that were in use during the study.41,44

This study was based on the survivors of a long-term observational investigation. Cholesterol levels often decline in the elderly, and single measurements in an older subject may misrepresent exposure.45 The importance of multiple measurements and time-integrated effects may be particularly evident when levels or habits change. The association of cigarette smoking with carotid stenosis is more complex, because long-term exposure is highly associated with stenosis and smoking cessation 10 years before the carotid evaluation was still associated with carotid stenosis in these analyses.

There are preventive implications of the significant associations between carotid stenosis and time-integrated measurements of traditional risk factors. Lower blood pressure, lower cholesterol levels, and abstention from smoking in middle adulthood might lead to less carotid stenosis in the elderly, along with less coronary heart disease and stroke.

Supported by the National Heart, Lung, and Blood Institute's Framingham Heart Study (contract N01-HC-38038) and by a grant (5R01-NS17950) from the National Institutes of Health.

Source Information

From the Framingham Heart Study, National Heart, Lung, and Blood Institute, Framingham, Mass. (P.W.F.W.); the National Heart, Lung, and Blood Institute, Bethesda, Md. (J.M.H.); and the Department of Mathematics, Boston University (R.B.D., H.S., A.M.B.), the Department of Neurology, Boston University School of Medicine (H.P., P.A.W.), and the Department of Radiology, Tufts University Medical Center (D.O.) — all in Boston.

Address reprint requests to Dr. Wilson at the Framingham Heart Study, National Heart, Lung, and Blood Institute, 5 Thurber St., Framingham, MA 01701.

References

References

  1. 1

    Stamler J, Wentworth DN, Neaton JD. Is the relationship between serum cholesterol and risk of death from coronary heart disease continuous and graded? Findings on the 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986;256:2823-2828
    CrossRef | Web of Science | Medline

  2. 2

    Anderson KM, Wilson PWF, Odell PM, Kannel WB. An updated coronary risk profile: a statement for health professionals. Circulation 1991;83:357-362

  3. 3

    Stamler J, Neaton JD, Wentworth DN. Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease. Hypertension 1989;13:Suppl:I-2

  4. 4

    O'Leary DH, Anderson KM, Wolf PA, Evans JC, Poehlman HW. Cholesterol and carotid atherosclerosis in older persons: the Framingham Study. Ann Epidemiol 1992;2:147-153
    CrossRef | Medline

  5. 5

    Salomaa V, Stinson V, Kark JD, Folsom AR, Davis CE, Wu KK. Association of fibrinolytic parameters with early atherosclerosis: the ARIC Study: Atherosclerosis Risk in Communities Study. Circulation 1995;91:284-290
    Web of Science | Medline

  6. 6

    Fabris F, Zanocchi M, Bo M, et al. Carotid plaque, aging, and risk factors: a study of 457 subjects. Stroke 1994;25:1133-1140
    CrossRef | Web of Science | Medline

  7. 7

    Mayberg MR, Wilson SE, Yatsu F, et al. Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis. JAMA 1991;266:3289-3294
    CrossRef | Web of Science | Medline

  8. 8

    North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445-453
    Full Text | Web of Science | Medline

  9. 9

    Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995;273:1421-1428
    CrossRef | Web of Science

  10. 10

    Crouse JR III, Byington RP, Bond MG, et al. Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II). Am J Cardiol 1995;75:455-459[Erratum, J Cardiol 1995;75:862.]
    CrossRef | Web of Science | Medline

  11. 11

    The European Carotid Surgery Trialists Collaborative Group. Risk of stroke in the distribution of an asymptomatic carotid artery. Lancet 1995;345:209-212
    Web of Science | Medline

  12. 12

    Folsom AR, Eckfeldt JH, Weitzman S, et al. Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity: Atherosclerosis Risk in Communities (ARIC) Study Investigators. Stroke 1994;25:66-73
    CrossRef | Web of Science | Medline

  13. 13

    Brown SA, Morrisett JD, Boerwinkle E, Hutchinson R, Patsch W. The relation of lipoprotein[a] concentrations and apolipoprotein[a] phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb 1993;13:1558-1566
    CrossRef | Medline

  14. 14

    Sharrett AR, Patsch W, Sorlie PD, Heiss G, Bond MG, Davis CE. Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb 1994;14:1098-1104
    CrossRef | Medline

  15. 15

    Tell GS, Polak JF, Ward BJ, Kittner SJ, Savage PJ, Robbins J. Relation of smoking with carotid artery wall thickness and stenosis in older adults: the Cardiovascular Health Study: the Cardiovascular Health Study (CHS) Collaborative Research Group. Circulation 1994;90:2905-2908
    Web of Science | Medline

  16. 16

    Kritchevsky SB, Shimakawa T, Tell GS, et al. Dietary antioxidants and carotid artery wall thickness: the ARIC Study: Atherosclerosis Risk in Communities Study. Circulation 1995;92:2142-2150
    Web of Science | Medline

  17. 17

    Benfante R, Reed D. Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly? JAMA 1990;263:393-396
    CrossRef | Web of Science | Medline

  18. 18

    Benfante R, Yano K, Hwang LJ, Curb JD, Kagan A, Ross W. Elevated serum cholesterol is a risk factor for both coronary heart disease and thromboembolic stroke in Hawaiian Japanese men: implications of shared risk. Stroke 1994;25:814-820
    CrossRef | Web of Science | Medline

  19. 19

    McNamara JR, Schaefer EJ. Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin Chim Acta 1987;166:1-8
    CrossRef | Web of Science | Medline

  20. 20

    Abell LL, Levy BB, Brodie BB, Kendall FE. A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem 1952;195:357-366
    Web of Science | Medline

  21. 21

    Anderson KM, Castelli WP, Levy D. Cholesterol and mortality: 30 years of follow-up from the Framingham Study. JAMA 1987;257:2176-2180
    CrossRef | Web of Science | Medline

  22. 22

    Testing hypotheses in multiple regression. In: Kleinbaum DG, Kupper LL, Muller KE. Applied regression analysis and other multivariable methods. 2nd ed. Boston: PWS–Kent Publishing, 1988:124-43.

  23. 23

    The multiple logistic regression model. In: Hosmer DW Jr, Leme-show S. Applied logistic regression. New York: John Wiley, 1989:25-37.

  24. 24

    Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study. Am J Med 1977;62:707-714
    CrossRef | Web of Science | Medline

  25. 25

    Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. Predicting coronary heart disease in middle-aged and older persons: the Framingham Study. JAMA 1977;238:497-499
    CrossRef | Web of Science | Medline

  26. 26

    Wilson PWF, Kannel WB. Hypercholesterolemia and coronary risk in the elderly: the Framingham Study. Am J Geriatr Cardiol 1993;2:52-56

  27. 27

    Kannel WB, Castelli WP. Is the serum total cholesterol an anachronism? Lancet 1979;2:950-951
    CrossRef | Web of Science | Medline

  28. 28

    Corti MC, Guralnik JM, Salive ME, et al. HDL cholesterol predicts coronary heart disease mortality in older persons. JAMA 1995;274:539-544
    CrossRef | Web of Science | Medline

  29. 29

    Salonen R, Seppanen K, Rauramaa R, Salonen JT. Prevalence of carotid atherosclerosis and serum cholesterol levels in eastern Finland. Arteriosclerosis 1988;8:788-792
    CrossRef | Medline

  30. 30

    Heiss G, Sharrett AR, Barnes R, Chambless LE, Szklo M, Alzola C. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol 1991;134:250-256
    Web of Science | Medline

  31. 31

    O'Leary DH, Polak JF, Kronmal RA, et al. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study: the CHS Collaborative Research Group. Stroke 1992;23:1752-1760
    CrossRef | Web of Science | Medline

  32. 32

    O'Leary DH, Polak JF, Kronmal RA, et al. Thickening of the carotid wall: a marker for atherosclerosis in the elderly? Cardiovascular Health Study Collaborative Research Group. Stroke 1996;27:224-231
    CrossRef | Web of Science | Medline

  33. 33

    Persson J, Formgren J, Israelsson B, Berglund G. Ultrasound-determined intima-media thickness and atherosclerosis: direct and indirect validation. Arterioscler Thromb 1994;14:261-264
    CrossRef | Medline

  34. 34

    Hoeg JM. Familial hypercholesterolemia: what the zebra can teach us about the horse. JAMA 1994;271:543-546
    CrossRef | Web of Science | Medline

  35. 35

    Hoeg JM, Feuerstein IM, Tucker EE. Detection and quantitation of calcific atherosclerosis by ultrafast computed tomography in children and young adults with homozygous familial hypercholesterolemia. Arterioscler Thromb 1994;14:1066-1074
    CrossRef | Medline

  36. 36

    Schmidt HH, Hill S, Makariou EV, Feuerstein IM, Dugi KA, Hoeg JM. Relation of cholesterol-year score to severity of calcific atherosclerosis and tissue deposition in homozygous familial hypercholesterolemia. Am J Cardiol 1996;77:575-580
    CrossRef | Web of Science | Medline

  37. 37

    Sidhu PS, Naoumova RP, Maher VMG, et al. The extracranial carotid artery in familial hypercholesterolaemia: relationship of intimal-medial thickness and plaque morphology with plasma lipids and coronary heart disease. J Cardiovasc Risk 1996;3:61-67
    CrossRef | Medline

  38. 38

    Kannel WB, Wolf PA, McGee DL, Dawber TR, McNamara P, Castelli WP. Systolic blood pressure, arterial rigidity, and risk of stroke: the Framingham Study. JAMA 1981;245:1225-1229
    CrossRef | Web of Science | Medline

  39. 39

    SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-3264
    CrossRef | Web of Science

  40. 40

    Wilson PWF. Cholesterol screening: once is not enough. Arch Intern Med 1995;155:2146-2147
    CrossRef | Web of Science | Medline

  41. 41

    Cooper GR, Myers GL, Smith SJ, Schlant RC. Blood lipid measurements: variations and practical utility. JAMA 1992;267:1652-1660
    CrossRef | Web of Science | Medline

  42. 42

    Cooper GR, Smith SJ, Myers GL, Sampson EJ, Magid E. Estimating and minimizing effects of biologic sources of variation by relative range when measuring the mean of serum lipids and lipoproteins. Clin Chem 1994;40:227-232
    Web of Science | Medline

  43. 43

    LaRosa JC, Hunninghake D, Bush D, et al. The cholesterol facts: a summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease: a joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. Circulation 1990;81:1721-1733
    CrossRef | Web of Science | Medline

  44. 44

    Current status of blood cholesterol measurement in clinical laboratories in the United States: a report from the Laboratory Standardization Panel of the National Cholesterol Education Program. Clin Chem 1988;34:193-201
    Web of Science | Medline

  45. 45

    Wilson PWF, Anderson KM, Harris T, Kannel WB, Castelli WP. Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. J Gerontol 1994;49:M252-M257
    Medline

Citing Articles (61)

Citing Articles

  1. 1

    M R Wofford, C M Rebholz, K Reynolds, J Chen, C-S Chen, L Myers, J Xu, D W Jones, P K Whelton, J He. (2011) Effect of soy and milk protein supplementation on serum lipid levels: a randomized controlled trial. European Journal of Clinical Nutrition
    CrossRef

  2. 2

    John J. Ricotta, Ali AbuRahma, Enrico Ascher, Mark Eskandari, Peter Faries, Brajesh K. Lal. (2011) Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease. Journal of Vascular Surgery 54:3, e1-e31
    CrossRef

  3. 3

    Tatjana Rundek, Joseph F. Polak. 2011. Cardiovascular Risk Factors and Carotid Ultrasound. , 158-176.
    CrossRef

  4. 4

    Thomas G. Brott, Jonathan L. Halperin, Suhny Abbara, J. Michael Bacharach, John D. Barr, Ruth L. Bush, Christopher U. Cates, Mark A. Creager, Susan B. Fowler, Gary Friday, Vicki S. Hertzberg, E. Bruce McIff, Wesley S. Moore, Peter D. Panagos, Thomas S. Riles, Robert H. Rosenwasser, Allen J. Taylor. (2011) 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease. Journal of the American College of Cardiology 57:8, e16-e94
    CrossRef

  5. 5

    Thomas G. Brott, Jonathan L. Halperin, Suhny Abbara, J. Michael Bacharach, John D. Barr, Ruth L. Bush, Christopher U. Cates, Mark A. Creager, Susan B. Fowler, Gary Friday, Vicki S. Hertzberg, E. Bruce McIff, Wesley S. Moore, Peter D. Panagos, Thomas S. Riles, Robert H. Rosenwasser, Allen J. Taylor. (2011) 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease: Executive Summary. Journal of the American College of Cardiology 57:8, 1002-1044
    CrossRef

  6. 6

    Robert D. Abbott, Aya Kadota, Katsuyuki Miura, Takehito Hayakawa, Takashi Kadowaki, Tomonori Okamura, Akira Okayama, Kamal H. Masaki, Hirotsugu Ueshima. (2011) Impairments in Activities of Daily Living in Older Japanese Men in Hawaii and Japan. Journal of Aging Research 2011, 1-8
    CrossRef

  7. 7

    Tzung-Dau Wang, Wayne H-H Sheu. (2011) From casual blood pressure measurement to long-term blood pressure burden: better elucidation of the association between versatile blood pressures and cardiovascular events. Hypertension Research 34:1, 49-51
    CrossRef

  8. 8

    Thomas G. Brott, Jonathan L. Halperin, Suhny Abbara, J. Michael Bacharach, John D. Barr, Ruth L. Bush, Christopher U. Cates, Mark A. Creager, Susan B. Fowler, Gary Friday, Vicki S. Hertzberg, E. Bruce McIff, Wesley S. Moore, Peter D. Panagos, Thomas S. Riles, Robert H. Rosenwasser, Allen J. Taylor, Alice K. Jacobs, Sidney C. Smith, Jeffery L. Anderson, Cynthia D. Adams, Nancy Albert, Christopher E. Buller, Mark A. Creager, Steven M. Ettinger, Robert A. Guyton, Jonathan L. Halperin, Judith S. Hochman, Sharon Ann Hunt, Harlan M. Krumholz, Frederick G. Kushner, Bruce W. Lytle, Rick A. Nishimura, E. Magnus Ohman, Richard L. Page, Barbara Riegel, William G. Stevenson, Lynn G. Tarkington, Clyde W. Yancy. (2011) 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease: Executive summary. Catheterization and Cardiovascular Interventionsn/a-n/a
    CrossRef

  9. 9

    Hiroyuki Sasai, Toshimi Sairenchi, Fujiko Irie, Emiko Otaka, Hiroyasu Iso, Kiyoji Tanaka, Hitoshi Ota, Takashi Muto. (2011) Long-term exposure to elevated blood pressure and mortality from cardiovascular disease in a Japanese population: the Ibaraki Prefectural Health Study. Hypertension Research 34:1, 139-144
    CrossRef

  10. 10

    Arch G Mainous, Vanessa A Diaz. (2010) Telomere length as a risk marker for cardiovascular disease: the next big thing?. Expert Review of Molecular Diagnostics 10:8, 969-971
    CrossRef

  11. 11

    Alessandro Mauriello, Giuseppe M. Sangiorgi, Renu Virmani, Santi Trimarchi, David R. Holmes, Frank D. Kolodgie, David G. Piepgras, Giulia Piperno, Doriana Liotti, Jagat Narula, Paolo Righini, Arnaldo Ippoliti, Luigi G. Spagnoli. (2010) A pathobiologic link between risk factors profile and morphological markers of carotid instability. Atherosclerosis 208:2, 572-580
    CrossRef

  12. 12

    Jong Bum Kwon, Kuhn Park, Si Young Choi, Chan Beom Park, Yong Hwan Kim, Sung Ho Her, Mahn Won Park, Jong Ho Lee. (2010) The Clinical Value of Intima-media Thickness in Patients with Stable Coronary Artery Disease and C-reactive Protein within Normal Limits. The Korean Journal of Thoracic and Cardiovascular Surgery 43:5, 482
    CrossRef

  13. 13

    Masao Watanabe, Kazumi Kimura, Yasuyuki Iguchi, Kensaku Shibazaki, Takao Urabe, Nobutaka Hattori. (2010) Peripheral Arterial Atherosclerosis in Patients with Extracranial, not Intracranial, Arterial Stenosis. Internal Medicine 49:15, 1515-1519
    CrossRef

  14. 14

    Hisatomi Arima, Yumihiro Tanizaki, Koji Yonemoto, Yasufumi Doi, Toshiharu Ninomiya, Jun Hata, Masayo Fukuhara, Kiyoshi Matsumura, Mitsuo Iida, Yutaka Kiyohara. (2009) Impact of blood pressure levels on different types of stroke: the Hisayama study. Journal of Hypertension 27:12, 2437-2443
    CrossRef

  15. 15

    Ming-Jer Hsieh, Chun-Chi Chen, Tsong-Hai Lee, Cheng-Hung Lee, Ming-Shien Wen, Fun-Chung Lin, I-Chang Hsieh, Delon Wu. (2009) Metabolic Syndrome and Homocysteine Level as Predictors of the Severity of Coronary Artery Disease in Patients With Carotid Stenosis. The American Journal of the Medical Sciences 338:6, 447-452
    CrossRef

  16. 16

    Lachezar Grozdinski, Mario Stankev, Kocho Dimitrovski. (2009) Ultrasound Screening of Multifocal Atherosclerosis. Macedonian Journal of Medical Sciences 2:2, 126-136
    CrossRef

  17. 17

    Laura L. Schott, Amy H. Kao, Amy Cunningham, Rachel P. Wildman, Lewis H. Kuller, Kim Sutton-Tyrrell, Mary Chester M. Wasko. (2009) Do Carotid Artery Diameters Manifest Early Evidence of Atherosclerosis in Women with Rheumatoid Arthritis?. Journal of Women's Health 18:1, 21-29
    CrossRef

  18. 18

    Jose R. Romero, Ramachandran S. Vasan, Alexa S. Beiser, Joseph F. Polak, Emelia J. Benjamin, Philip A. Wolf, Sudha Seshadri. (2008) Association of Carotid Artery Atherosclerosis With Circulating Biomarkers of Extracellular Matrix Remodeling: The Framingham Offspring Study. Journal of Stroke and Cerebrovascular Diseases 17:6, 412-417
    CrossRef

  19. 19

    D. I. Hadjiev, P. P. Mineva. (2008) Antihypertensive treatment in elderly hypertensives without a history of stroke and the risk of cognitive disorders. Acta Neurologica Scandinavica 118:3, 139-145
    CrossRef

  20. 20

    Emire Seyahi, Serdal Ugurlu, Rana Cumali, Huriye Balci, Oktay Ozdemir, Melike Melikoglu, Gulen Hatemi, Izzet Fresko, Vedat Hamuryudan, Sebahattin Yurdakul, Hasan Yazici. (2008) Atherosclerosis in Behçet's Syndrome. Seminars in Arthritis and Rheumatism 38:1, 1-12
    CrossRef

  21. 21

    Dong-Jun Kim, Jaclyn Bergstrom, Elizabeth Barrett-Connor, Gail A. Laughlin. (2008) Visceral Adiposity and Subclinical Coronary Artery Disease in Elderly Adults: Rancho Bernardo Study. Obesity 16:4, 853-858
    CrossRef

  22. 22

    Sae Young Jae, Mercedes R. Carnethon, Kevin S. Heffernan, Yoon-Ho Choi, Moon-Kyu Lee, Won Hah Park, Bo Fernhall. (2008) Slow heart rate recovery after exercise is associated with carotid atherosclerosis. Atherosclerosis 196:1, 256-261
    CrossRef

  23. 23

    Robert D. Abbott, Hirotsugu Ueshima, Kamal H. Masaki, Bradley J. Willcox, Beatriz L. Rodriguez, Alvin Ikeda, Katsuhiko Yano, Lon R. White, J. David Curb. (2007) Coronary Artery Calcification and Total Mortality in Elderly Men. Journal of the American Geriatrics Society 55:12, 1948-1954
    CrossRef

  24. 24

    Pierre Amarenco, P Gabriel Steg. (2007) The paradox of cholesterol and stroke. The Lancet 370:9602, 1803-1804
    CrossRef

  25. 25

    Sae Young Jae, Mercedes R. Carnethon, Kevin S. Heffernan, Yoon-Ho Choi, Moon-Kyu Lee, Bo Fernhall. (2007) Association between cardiorespiratory fitness and prevalence of carotid atherosclerosis among men with hypertension. American Heart Journal 153:6, 1001-1005
    CrossRef

  26. 26

    Mária Tünde Magyar, Dániel Bereczki. (2007) Cholesterol and the cerebral circulation. Future Lipidology 2:2, 211-228
    CrossRef

  27. 27

    Adnan I. Qureshi, Andrei V. Alexandrov, Charles H. Tegeler, Robert W. Hobson, J. Dennis Baker, L. Nelson Hopkins. (2007) Guidelines for Screening of Extracranial Carotid Artery Disease: A Statement for Healthcare Professionals from the Multidisciplinary Practice Guidelines Committee of the American Society of Neuroimaging; Cosponsored by the Society of Vascular and Interventional Neurology. Journal of Neuroimaging 17:1, 19-47
    CrossRef

  28. 28

    Levente Kerenyi, Laszlo Mihalka, Laszlo Csiba, Hajnalka Bacso, Daniel Bereczki. (2006) Role of hyperlipidemia in atherosclerotic plaque formation in the internal carotid artery. Journal of Clinical Ultrasound 34:6, 283-288
    CrossRef

  29. 29

    Sae Young Jae, Bo Fernhall, Kevin S Heffernan, Mira Kang, Moon-Kyu Lee, Yoon Ho Choi, Kyung Pyo Hong, Eui Soo Ahn, Won Hah Park. (2006) Exaggerated blood pressure response to exercise is associated with carotid atherosclerosis in apparently healthy men. Journal of Hypertension 24:5, 881-887
    CrossRef

  30. 30

    J. Falkensammer, G. Fraedrich. (2005) Therapieplanung bei gleichzeitigem Vorliegen von koronarer Herzkrankheit und Karotisstenose. Gefässchirurgie 10:5, 336-340
    CrossRef

  31. 31

    Bertram W. Roberts, Irina Cech. (2005) Association of Type 2 Diabetes Mellitus and Seroprevalence for Cytomegalovirus. Southern Medical Journal 98:7, 686-692
    CrossRef

  32. 32

    Jos&eacute; Vivancos-Mora, Antonio C. Gil-N&uacute;&ntilde;ez. (2005) Lipids and Stroke: The Opportunity of Lipid-Lowering Treatment. Cerebrovascular Diseases 20:2, 53-67
    CrossRef

  33. 33

    Peter W.F Wilson. (2004) Estimating cardiovascular disease risk and the metabolic syndrome: a Framingham view. Endocrinology & Metabolism Clinics of North America 33:3, 467-481
    CrossRef

  34. 34

    J. D. Curb. (2004) High Density Lipoprotein Cholesterol and the Risk of Stroke in Elderly Men: The Honolulu Heart Program. American Journal of Epidemiology 160:2, 150-157
    CrossRef

  35. 35

    D. W. Dodick, I. Meissner, F. B. Meyer, H. J. Cloft. (2004) Evaluation and Management of Asymptomatic Carotid Artery Stenosis. Mayo Clinic Proceedings 79:7, 937-944
    CrossRef

  36. 36

    Barbara E. Millen, Paula A. Quatromoni, Byung-Ho Nam, Catherine E. O’Horo, Joseph F. Polak, Philip A. Wolf, Ralph B. D’Agostino. (2004) Dietary patterns, smoking, and subclinical heart disease in women: opportunities for primary prevention from the Framingham nutrition studies. Journal of the American Dietetic Association 104:2, 208-214
    CrossRef

  37. 37

    Richard W Grant, James B Meigs. (2004) Should the Insulin Resistance Syndrome be Treated in the Elderly?. Drugs & Aging 21:3, 141-151
    CrossRef

  38. 38

    Robert D. Abbott, J.David Curb, Beatriz L. Rodriguez, Kamal H. Masaki, Jordan S. Popper, G.Webster Ross, Helen Petrovitch. (2003) Age-related changes in risk factor effects on the incidence of thromboembolic and hemorrhagic stroke. Journal of Clinical Epidemiology 56:5, 479-486
    CrossRef

  39. 39

    Christoph Terborg, Silke Bramer, Cornelius Weiller, Joachim Röther. (2002) Short-term effect of cigarette smoking on CO2-induced vasomotor reactivity in man. Journal of the Neurological Sciences 205:1, 15-20
    CrossRef

  40. 40

    R SAMSON. (2002) Pharmaceutical initiatives to combat atherosclerosis—What to do with the good, the bad, and the ugly lipoproteins. Seminars in Vascular Surgery 15:4, 204-215
    CrossRef

  41. 41

    K. Wilfert, H. Guski, P. B. Persson, H. M. Stauss. (2002) Cardiovascular responses to angiotensin II in atherosclerosis. Acta Physiologica Scandinavica 176:2, 95-100
    CrossRef

  42. 42

    Martin Hausberg, Markus Kosch, Michael Barenbrock. (2002) Smoking, blood pressure and cardiovascular risk. Journal of Hypertension 20:9, 1699-1701
    CrossRef

  43. 43

    Robert D Abbott, J.David Curb, Beatriz L Rodriguez, Kamal H Masaki, Katsuhiko Yano, Irwin J Schatz, G.Webster Ross, Helen Petrovitch. (2002) Age-Related Changes in Risk Factor Effects on the Incidence of Coronary Heart Disease. Annals of Epidemiology 12:3, 173-181
    CrossRef

  44. 44

    J. Falkensammer, G. Fraedrich. (2001) Koronare Herzkrankheit und Carotisstenose: ein- oder zweizeitiges Vorgehen?. European Surgery-Acta Chirurgica Austriaca 33:6, 280-283
    CrossRef

  45. 45

    Marco Zimarino, Lucia Cappelletti, Vincenzo Venarucci, Sabina Gallina, Maurizio Scarpignato, Nadia Acciai, Antonio Maria Calafiore, Antonio Barsotti, Raffaele De Caterina. (2001) Age-dependence of risk factors for carotid stenosis: an observational study among candidates for coronary arteriography. Atherosclerosis 159:1, 165-173
    CrossRef

  46. 46

    Robert D Abbott, Beatriz L Rodriguez, Helen Petrovitch, Katsuhiko Yano, Irwin J Schatz, Jordan S Popper, Kamal H Masaki, G.Webster Ross, J.David Curb. (2001) Ankle–brachial blood pressure in elderly men and the risk of stroke. Journal of Clinical Epidemiology 54:10, 973-978
    CrossRef

  47. 47

    SM Clee, O Loubser, J Collins, JJP Kastelein, MR Hayden. (2001) The LPL S447X cSNP is associated with decreased blood pressure and plasma triglycerides, and reduced risk of coronary artery disease. Clinical Genetics 60:4, 293-300
    CrossRef

  48. 48

    Laura Garvey, Michel S. Makaroun, Visala S. Muluk, Marshall W. Webster, Satish C. Muluk. (2000) Etiologic factors in progression of carotid stenosis: A 10-year study in 905 patients. Journal of Vascular Surgery 31:1, 31-38
    CrossRef

  49. 49

    Daniel T. Lackland, Brent M. Egan, Dominic A. Sica. (1999) Consortium for Southeastern Hypertension Control. The American Journal of the Medical Sciences 318:6, 365
    CrossRef

  50. 50

    Christian J Wiedermann, Stefan Kiechl, Stefan Dunzendorfer, Peter Schratzberger, Georg Egger, Friedrich Oberhollenzer, Johann Willeit. (1999) Association of endotoxemia with carotid atherosclerosis and cardiovascular disease. Journal of the American College of Cardiology 34:7, 1975-1981
    CrossRef

  51. 51

    Amy A Hakim, J.David Curb, Cecil M Burchfiel, Beatriz L Rodriguez, Dan S Sharp, Katsuhiko Yano, Robert D Abbott. (1999) Screening for Coronary Heart Disease in Elderly Men Based on Current and Past Cholesterol Levels. Journal of Clinical Epidemiology 52:12, 1257-1265
    CrossRef

  52. 52

    F.Javier Nieto, Ana Diez-Roux, Moyses Szklo, George W Comstock, A.Richey Sharrett. (1999) Short- and Long-Term Prediction of Clinical and Subclinical Atherosclerosis by Traditional Risk Factors. Journal of Clinical Epidemiology 52:6, 559-567
    CrossRef

  53. 53

    M. Pfeifer, R. Verhovec, B. Zizek. (1999) Growth hormone (GH) andatherosclerosis: changes in morphology and function of major arteries during GH treatment. Growth Hormone & IGF Research 9, 25-30
    CrossRef

  54. 54

    ERROL D. CROOK. (1999) The Role of Hypertension, Obesity, and Diabetes in Causing Renal Vascular Disease. The American Journal of the Medical Sciences 317:3, 183-188
    CrossRef

  55. 55

    James F. Benenati. (1999) Risk Assessment and Physical Examination in Vascular Disease. Journal of Vascular and Interventional Radiology 10:2, 311-316
    CrossRef

  56. 56

    O'Leary, Daniel H., Polak, Joseph F., Kronmal, Richard A., Manolio, Teri A., Burke, Gregory L., Wolfson, Sidney K. Jr., . (1999) Carotid-Artery Intima and Media Thickness as a Risk Factor for Myocardial Infarction and Stroke in Older Adults. New England Journal of Medicine 340:1, 14-22
    Full Text

  57. 57

    Tai Sakurabayashi, Makoto Fujimoto, Yoshiji Takaesu, Susumu Haginoshita, Shin Goto, Ikuo Aoike, Shigeru Miyazaki, Yutaka Koda, Yasuko Yuasa, Shinji Sakai, Masashi Suzuki, Yoshihei Hirasawa. (1999) Association Between Plasma Homocysteine Concentration and Carotid Atherosclerosis in Hemodialysis Patients. Japanese Circulation Journal 63:9, 692-696
    CrossRef

  58. 58

    Lewis Kuller. (1998) Hyperlipidaemia and cardiovascular disease. Current Opinion in Lipidology 9:4, 375-377
    CrossRef

  59. 59

    Christopher J. Bates, Catherine M. Walmsley, Ann Prentice, Steven Finch. (1998) Does vitamin C reduce blood pressure?Results of a large study of people aged 65 or older. Journal of Hypertension 16:7, 925-932
    CrossRef

  60. 60

    Aldo Celentano, Francesco P. Mancini, Marina Crivaro, Vittorio Palmieri, Valentino De Stefano, L Aldo Ferrara, Giovanni Di Minno, Giovanni de Simone. (1998) Influence of cardiovascular risk factors on relation between angiotensin converting enzyme-gene polymorphism and blood pressure in arterial hypertension. Journal of Hypertension 16:7, 985-991
    CrossRef

  61. 61

    James F. Benenati. (1998) Risk Assessment and Physical Examination in Vascular Disease. Journal of Vascular and Interventional Radiology 9:1, 264-269
    CrossRef